JPMorgan Chase & Co. Lowers Position in agilon health, inc. (NYSE:AGL)

JPMorgan Chase & Co. reduced its stake in agilon health, inc. (NYSE:AGL) by 82.4% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 249,346 shares of the company’s stock after selling 1,166,073 shares during the period. JPMorgan Chase & Co. owned approximately 0.06% of agilon health worth $474,000 at the end of the most recent quarter.

Other large investors also recently bought and sold shares of the company. Symphony Financial Services Inc. increased its position in shares of agilon health by 44.3% during the fourth quarter. Symphony Financial Services Inc. now owns 23,000 shares of the company’s stock valued at $44,000 after acquiring an additional 7,058 shares during the last quarter. Signaturefd LLC increased its holdings in agilon health by 143.0% in the 4th quarter. Signaturefd LLC now owns 14,388 shares of the company’s stock valued at $27,000 after purchasing an additional 8,467 shares during the last quarter. Oak Thistle LLC acquired a new stake in agilon health in the 4th quarter valued at approximately $25,000. Ieq Capital LLC acquired a new position in agilon health during the fourth quarter worth $26,000. Finally, Raymond James Financial Inc. acquired a new position in agilon health during the fourth quarter worth $33,000.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on AGL shares. Stifel Nicolaus boosted their price objective on agilon health from $2.00 to $3.00 and gave the company a “hold” rating in a report on Wednesday, February 26th. Sanford C. Bernstein upgraded shares of agilon health from a “market perform” rating to an “outperform” rating and boosted their price target for the stock from $3.30 to $8.50 in a research note on Tuesday, April 8th. Needham & Company LLC reissued a “hold” rating on shares of agilon health in a research note on Friday, March 21st. TD Cowen upped their target price on shares of agilon health from $3.50 to $6.00 and gave the stock a “hold” rating in a research note on Tuesday, April 15th. Finally, Citigroup upgraded shares of agilon health from a “neutral” rating to a “buy” rating and increased their target price for the stock from $3.25 to $5.00 in a report on Friday, April 25th. Two equities research analysts have rated the stock with a sell rating, twelve have given a hold rating and four have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, agilon health currently has a consensus rating of “Hold” and an average target price of $4.81.

agilon health Trading Down 8.3 %

NYSE:AGL opened at $3.91 on Friday. agilon health, inc. has a 1 year low of $1.50 and a 1 year high of $7.73. The stock has a market cap of $1.61 billion, a P/E ratio of -4.16 and a beta of 0.38. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.29 and a current ratio of 1.29. The stock has a 50-day simple moving average of $4.22 and a 200-day simple moving average of $3.16.

agilon health Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.